Pentwater Capital Management’s PureTech Health PRTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $863K | Buy |
50,000
+16,440
| +49% | +$284K | 0.01% | 57 |
|
|
2025
Q1 | $664K | Buy |
33,560
+9,449
| +39% | +$187K | 0.01% | 60 |
|
|
2024
Q4 | $445K | Sell |
24,111
-889
| -4% | -$16.4K | ﹤0.01% | 50 |
|
|
2024
Q3 | $515K | Buy |
25,000
+8,807
| +54% | +$182K | 0.01% | 46 |
|
|
2024
Q2 | $405K | Sell |
16,193
-807
| -5% | -$20.2K | 0.01% | 50 |
|
|
2024
Q1 | $485K | Buy |
17,000
+6,756
| +66% | +$193K | 0.01% | 54 |
|
|
2023
Q4 | $289K | Buy |
+10,244
| New | +$289K | ﹤0.01% | 64 |
|